Omicron: Pfizer-BioNTech COVID-19 vaccine may only partially protect against new variant, study suggests
Fox News
A new study led by the Africa Health Research Institute reportedly suggests that the omicron COVID-19 variant escapes antibody immunity induced by two doses of the Pfizer-BioNTech vaccine.
Six of the participants had no previous record of SARS-CoV-2 infection nor detectable nucleocapsid antibodies indicative of previous infection.
There was an observed 41-fold decline in vaccine-induced neutralizing antibodies compared to the ancestral strain of the virus, the researchers said.
More Related News